Challenging Assumptions About Minority Participation in US Clinical Research

Although extensive research addresses minorities’ low participation in clinical research, most focuses almost exclusively on therapeutic trials. The existing literature might mask important issues concerning minorities’ participation in clinical trials, and minorities might actually be overrepresent...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	American journal of public health (1971) Ročník 101; číslo 12; s. 2217 - 2222
Hlavní autoři:	Fisher, Jill A., Kalbaugh, Corey A.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Washington, DC American Public Health Association 01.12.2011
Témata:	African Americans African Americans - statistics & numerical data Biological and medical sciences Biomedical research Clinical research Clinical trials Clinical Trials as Topic - statistics & numerical data Clinical Trials, Phase I as Topic Clinical Trials, Phase III as Topic Disenfranchisement Elimination Equality Ethics Ethics, Research General aspects Health care Hispanic Americans Hispanic Americans - statistics & numerical data Human subjects Humans Literature Medical research Medical sciences Minority & ethnic groups Minority groups Minority Groups - statistics & numerical data Minority set aside programs Miscellaneous Participation Patient Participation - statistics & numerical data Patient Selection Public health Public health. Hygiene Public health. Hygiene-occupational medicine Syphilis United States Volunteers Winning Policy Change Womens health United States North America America Participation Clinical research Minority Public health
ISSN:	0090-0036, 1541-0048, 1541-0048
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Popis
Shrnutí:	Although extensive research addresses minorities’ low participation in clinical research, most focuses almost exclusively on therapeutic trials. The existing literature might mask important issues concerning minorities’ participation in clinical trials, and minorities might actually be overrepresented in phase I safety studies that require the participation of healthy volunteers. It is critical to consider the entire spectrum of clinical research when discussing the participation of disenfranchised groups; the literature on minorities’ distrust, poor access, and other barriers to trial participation needs reexamination. Minority participation in clinical trials is an important topic in public health discussions because this representation touches on issues of equality and the elimination of disparities, which are core values of the field.
Bibliografie:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 The authors contributed equally to the development and writing of this article. Contributors
ISSN:	0090-0036 1541-0048 1541-0048
DOI:	10.2105/AJPH.2011.300279